Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,441 | 1,216 | 90.6% |
| Consulting Fee | $1,850 | 1 | 8.6% |
| Education | $172.89 | 7 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,321 | 166 | $0 (2022) |
| PFIZER INC. | $3,174 | 86 | $0 (2022) |
| ABBVIE INC. | $2,478 | 190 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,354 | 90 | $0 (2022) |
| UCB, Inc. | $1,185 | 64 | $0 (2022) |
| Janssen Biotech, Inc. | $1,180 | 68 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $1,139 | 82 | $0 (2021) |
| Lilly USA, LLC | $1,059 | 74 | $0 (2022) |
| Mallinckrodt Enterprises LLC | $929.48 | 50 | $0 (2019) |
| Horizon Therapeutics plc | $628.32 | 58 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $30.52 | 1 | Bio Products Laboratory USA, Inc. ($30.52) |
| 2022 | $4,036 | 117 | PFIZER INC. ($1,953) |
| 2021 | $2,850 | 159 | Amgen Inc. ($644.84) |
| 2020 | $2,961 | 174 | Amgen Inc. ($693.35) |
| 2019 | $3,927 | 265 | Amgen Inc. ($450.90) |
| 2018 | $4,035 | 281 | Amgen Inc. ($601.44) |
| 2017 | $3,624 | 227 | AbbVie, Inc. ($493.01) |
All Payment Transactions
1,224 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/05/2023 | Bio Products Laboratory USA, Inc. | Gammaplex (Drug), Coagadex | Food and Beverage | Cash or cash equivalent | $30.52 | General |
| Category: IVIG | ||||||
| 11/25/2022 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $1,850.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/29/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: Immunology | ||||||
| 09/22/2022 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Inflammation | ||||||
| 09/21/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/15/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Immunology | ||||||
| 09/13/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Immunology | ||||||
| 09/08/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Immunology | ||||||
| 09/08/2022 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 08/30/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: IMMUNOLOGY | ||||||
| 08/25/2022 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Inflammation | ||||||
| 08/22/2022 | Amgen Inc. | Tavneos (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Not Applicable | ||||||
| 08/18/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: Inflammation | ||||||
| 08/18/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Immunology | ||||||
| 08/17/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Immunology | ||||||
| 08/16/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.39 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Immunology | ||||||
| 08/04/2022 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Inflammation and Autoimmunity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 702 | 4,450 | $335,711 | $157,810 |
| 2021 | 19 | 1,101 | 11,977 | $1.1M | $549,606 |
| 2020 | 19 | 1,161 | 10,811 | $1.0M | $546,123 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 407 | 857 | $162,830 | $78,789 | 48.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 40 | 3,180 | $112,000 | $53,536 | 47.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 75 | 95 | $25,555 | $13,510 | 52.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $10,353 | $4,445 | 42.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 28 | 56 | $13,076 | $3,351 | 25.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $3,726 | $2,056 | 55.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 57 | 120 | $5,520 | $1,336 | 24.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 35 | 81 | $1,130 | $404.73 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $1,521 | $381.76 | 25.1% |
| J9312 | Injection, rituximab, 10 mg | Office | 2021 | 14 | 2,700 | $356,500 | $192,544 | 54.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 510 | 1,382 | $229,596 | $132,030 | 57.5% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2021 | 12 | 2,373 | $235,188 | $80,422 | 34.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 46 | 4,452 | $126,817 | $73,606 | 58.0% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 41 | 169 | $58,040 | $21,417 | 36.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 78 | 104 | $24,284 | $14,727 | 60.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 65 | 65 | $20,745 | $10,986 | 53.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 25 | 26 | $7,389 | $4,317 | 58.4% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 28 | 154 | $16,212 | $4,204 | 25.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 32 | 61 | $9,105 | $3,598 | 39.5% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 14 | 43 | $4,530 | $3,100 | 68.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 49 | $6,437 | $2,442 | 37.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 68 | 213 | $11,210 | $2,407 | 21.5% |
| 96374 | Injection of drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 14 | 31 | $3,162 | $1,095 | 34.6% |
| 20605 | Aspiration and/or injection of medium joint or joint capsule | Office | 2021 | 18 | 23 | $2,606 | $1,042 | 40.0% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 23 | 23 | $1,440 | $993.14 | 69.0% |
About Dr. Jack Lichtenstein, MD
Dr. Jack Lichtenstein, MD is a Internal Medicine healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609844224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Lichtenstein, MD has received a total of $21,464 in payments from pharmaceutical and medical device companies, with $30.52 received in 2023. These payments were reported across 1,224 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($19,441).
As a Medicare-enrolled provider, Lichtenstein has provided services to 2,964 Medicare beneficiaries, totaling 27,238 services with total Medicare billing of $1.3M. Data is available for 3 years (2020–2022), covering 47 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Annapolis, MD
- Active Since 03/09/2006
- Last Updated 02/21/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609844224
Products in Payments
- XELJANZ (Drug) $2,845
- Enbrel (Biological) $2,312
- COSENTYX (Biological) $1,306
- ACTHAR (Biological) $1,285
- Cimzia (Drug) $1,185
- ORENCIA (Biological) $1,139
- Humira (Biological) $1,040
- TALTZ (Drug) $833.61
- RINVOQ (Biological) $553.76
- Rituxan (Biological) $420.84
- REMICADE (Biological) $365.91
- Otezla (Drug) $365.52
- RAYOS (Drug) $359.97
- SIMPONI ARIA (Biological) $341.59
- VIMOVO (Drug) $324.08
- TREMFYA (Drug) $303.98
- Tymlos (Biological) $289.55
- KEVZARA SARILUMAB INJECTION (Biological) $274.62
- LUPKYNIS (Drug) $267.63
- AVSOLA (Biological) $266.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Annapolis
Dr. Brian Harvey, Md, MD
Internal Medicine — Payments: $355,038
Aditya Chopra, Md, MD
Internal Medicine — Payments: $86,888
James Welker, D.o, D.O
Internal Medicine — Payments: $29,365
Dr. Darshana Purohit, Md, MD
Internal Medicine — Payments: $28,062
Dr. Prasad Savana, Md, MD
Internal Medicine — Payments: $17,282
Alan Weiss, Md, MD
Internal Medicine — Payments: $10,194